Early studies in animal models of oxygen induced retinopathy (OIR) showed that supplemental VEGF at the onset of hyperoxia significantly decreased both initial vaso-obliteration and the subsequent neovascularization characteristic of ROP, and that inhibition of VEGF was a viable treatment for neovascular disease once established [32–34]. Here, VEGFA is linked to retinopathy of prematurity.